胃腺癌的免疫疗法 - - 一个快速发展的治疗领域
1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia; Department of Medical Oncology, Northern Health, Epping, Australia.
Critical reviews in oncology/hematology
|September 15, 2025
概括
胃癌 (GC) 是全球癌症死亡的主要原因. 本综述详细介绍了免疫疗法使用,生物标志物和胃和胃食道结癌的新治疗方法,为改善患者的治疗结果提供了希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胃肠病学 胃肠病学
背景情况:
- 胃癌 (GC) 是一个重要的全球健康挑战,患者的预后不佳.
- 尽管治疗方面取得了进展,但对晚期患者的有效治疗方法有限.
- 免疫疗法,特别是免疫检查点抑制剂,在治疗GC和胃食道结 (GEJ) 腺癌方面表现有前途.
研究的目的:
- 为了审查胃癌的分子亚型.
- 总结早期和晚期GC/GEJ免疫治疗的证据.
- 讨论用于GC治疗的生物标志物和新型免疫疗法.
主要方法:
- 临床试验和关于胃癌治疗的研究的文献综述.
- 对GC/GEJ不同阶段的免疫疗法疗效数据的分析.
- 探索当前和新兴的生物标志物和治疗策略.
主要成果:
- 免疫疗法越来越多地用于GC/GEJ的所有治疗环境.
- 证据支持在外科手术期间治疗早期疾病的免疫疗法.
- 与化疗和向药物的联合疗法在转移性疾病中是有效的.
结论:
- 免疫疗法代表了胃癌治疗的关键进展.
- 了解分子亚型和生物标志物是优化免疫治疗的关键.
- 新型免疫治疗药物有可能改善GC患者的生存率.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Vaccines
974
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
974
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
